ESR1 and breast cancer: In their case-control study, Jiao et al. showed that serum RBP4 levels were positively associated with breast cancer risk among patients with lower BMI (<25 kg/m2) and that patients with ER- or PR-negative tumors possessed significantly higher serum levels of RBP4 [25].